154 related articles for article (PubMed ID: 22198560)
1. Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.
Liu H; Wei Q; Gershenwald JE; Prieto VG; Lee JE; Duvic M; Grimm EA; Wang LE
Melanoma Res; 2012 Apr; 22(2):169-75. PubMed ID: 22198560
[TBL] [Abstract][Full Text] [Related]
2. Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma.
Wang LE; Huang YJ; Yin M; Gershenwald JE; Prieto VG; Lee JE; Duvic M; Grimm EA; Wei Q
Eur J Cancer; 2011 Jan; 47(1):107-15. PubMed ID: 20655738
[TBL] [Abstract][Full Text] [Related]
3. Haplotype effects on matrix metalloproteinase-1 gene promoter activity in cancer cells.
Pearce EG; Laxton RC; Pereira AC; Ye S
Mol Cancer Res; 2007 Mar; 5(3):221-7. PubMed ID: 17339606
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
Padala C; Tupurani MA; Puranam K; Gantala S; Shyamala N; Kondapalli MS; Gundapaneni KK; Mudigonda S; Galimudi RK; Kupsal K; Nanchari SR; Chavan U; Chinta SK; Mukta S; Satti V; Hanumanth SR
PLoS One; 2017; 12(9):e0184448. PubMed ID: 28961241
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-1 (MMP-1) Promoter polymorphisms are well linked with lower stomach tumor formation in eastern Indian population.
Dey S; Ghosh N; Saha D; Kesh K; Gupta A; Swarnakar S
PLoS One; 2014; 9(2):e88040. PubMed ID: 24505369
[TBL] [Abstract][Full Text] [Related]
6. The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China.
Shan K; Ying W; Jian-Hui Z; Wei G; Na W; Yan L
Mol Hum Reprod; 2005 Jun; 11(6):423-7. PubMed ID: 15879464
[TBL] [Abstract][Full Text] [Related]
7. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.
Howell WM; Turner SJ; Collins A; Bateman AC; Theaker JM
Eur J Immunogenet; 2002 Feb; 29(1):17-23. PubMed ID: 11841484
[TBL] [Abstract][Full Text] [Related]
8. A functional polymorphism in the matrix metalloproteinase-1 gene promoter is associated with susceptibility and aggressiveness of head and neck cancer.
O-charoenrat P; Leksrisakul P; Sangruchi S
Int J Cancer; 2006 May; 118(10):2548-53. PubMed ID: 16353148
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis.
Bradbury PA; Zhai R; Hopkins J; Kulke MH; Heist RS; Singh S; Zhou W; Ma C; Xu W; Asomaning K; Ter-Minassian M; Wang Z; Su L; Christiani DC; Liu G
Carcinogenesis; 2009 May; 30(5):793-8. PubMed ID: 19321798
[TBL] [Abstract][Full Text] [Related]
10. Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis.
Dörr S; Lechtenböhmer N; Rau R; Herborn G; Wagner U; Müller-Myhsok B; Hansmann I; Keyszer G
Arthritis Res Ther; 2004; 6(3):R199-207. PubMed ID: 15142265
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.
Sauter W; Rosenberger A; Beckmann L; Kropp S; Mittelstrass K; Timofeeva M; Wölke G; Steinwachs A; Scheiner D; Meese E; Sybrecht G; Kronenberg F; Dienemann H; ; Chang-Claude J; Illig T; Wichmann HE; Bickeböller H; Risch A
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1127-35. PubMed ID: 18483334
[TBL] [Abstract][Full Text] [Related]
12. Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression.
Sun T; Gao Y; Tan W; Ma S; Zhang X; Wang Y; Zhang Q; Guo Y; Zhao D; Zeng C; Lin D
Clin Cancer Res; 2006 Dec; 12(23):7009-17. PubMed ID: 17145822
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival.
Li H; Wang Y; Liu H; Shi Q; Xu Y; Wu W; Zhu D; Amos CI; Fang S; Lee JE; Han J; Wei Q
Int J Cancer; 2017 Mar; 140(6):1270-1279. PubMed ID: 27914105
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival.
Dai W; Liu H; Chen K; Xu X; Qian D; Luo S; Amos CI; Lee JE; Li X; Nan H; Li C; Wei Q
Mol Carcinog; 2020 Jun; 59(6):640-650. PubMed ID: 32232919
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma.
Kondo S; Wakisaka N; Schell MJ; Horikawa T; Sheen TS; Sato H; Furukawa M; Pagano JS; Yoshizaki T
Int J Cancer; 2005 Jun; 115(3):368-76. PubMed ID: 15688379
[TBL] [Abstract][Full Text] [Related]
16. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival.
Chen K; Liu H; Liu Z; Bloomer W; Amos CI; Lee JE; Li X; Nan H; Wei Q
Mol Carcinog; 2019 Nov; 58(11):2091-2103. PubMed ID: 31435991
[TBL] [Abstract][Full Text] [Related]
18. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma.
Howell WM; Bateman AC; Turner SJ; Collins A; Theaker JM
Genes Immun; 2002 Jun; 3(4):229-32. PubMed ID: 12058259
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanoma.
Cotignola J; Chou JF; Roy P; Mitra N; Busam K; Halpern AC; Orlow I
J Invest Dermatol; 2012 May; 132(5):1471-8. PubMed ID: 22336942
[TBL] [Abstract][Full Text] [Related]
20. Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma.
Cotignola J; Reva B; Mitra N; Ishill N; Chuai S; Patel A; Shah S; Vanderbeek G; Coit D; Busam K; Halpern A; Houghton A; Sander C; Berwick M; Orlow I
BMC Med Genet; 2007 Mar; 8():10. PubMed ID: 17346338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
